Stay updated on AFFINE Clinical Trial: PF-07055480 in Severe Hemophilia A
Sign up to get notified when there's something new on the AFFINE Clinical Trial: PF-07055480 in Severe Hemophilia A page.

Latest updates to the AFFINE Clinical Trial: PF-07055480 in Severe Hemophilia A page
- Check4 days agoChange DetectedThe ClinicalTrials.gov record for Pfizer’s Phase 3 gene-therapy study for hemophilia A is displayed, including its eligibility criteria, locations, outcome measures, and study documents.SummaryDifference83%

- Check11 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0 on the 403 error page.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA sitewide NIH announcement about terminology changes was added, and the site revision advanced from v3.7.1 to v3.7.2; the study record still displays a 403 Forbidden error.SummaryDifference1%

- Check32 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the AFFINE hemophilia A study record, preventing access to its study details, eligibility criteria, locations, and results.SummaryDifference20%

- Check39 days agoChange DetectedThe study record for Pfizer’s Phase 3 hemophilia A gene-therapy trial is displayed, including eligibility criteria, study locations, outcome measures, and posted results and documents.SummaryDifference86%

- Check46 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the usual study record view. As a result, users cannot access the study details.SummaryDifference0.5%

Stay in the know with updates to AFFINE Clinical Trial: PF-07055480 in Severe Hemophilia A
Enter your email address, and we'll notify you when there's something new on the AFFINE Clinical Trial: PF-07055480 in Severe Hemophilia A page.